Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Sotagliflozin Hail Mary? Lexicon Seeks Opportunity For Formal Hearing On FDA Intent To Deny Approval
Mar 03 2021
•
By
Derrick Gingery
US FDA denied two formal requests for dispute resolution related to sotagliflozin after issuing a complete response letter to original application holder Sanofi . • Source: Shutterstock
More from US FDA
More from Agency Leadership